Ventripoint Unveils a Global Model for A.I.-Enhanced Heart Care through Partnership with the Nisga'a Valley Health Authority

(TheNewswire)

New care delivery model to provideadvanced cardiac imaging to remote and Indigenous communities inBritish Columbia, across Canada, and worldwide.

Toronto, Ontario – TheNewswire - December 12, 2025 -Ventripoint Diagnostics Ltd. (" Ventripoint ",“ VPT ” or the " Company "), (TSXV:VPT; OTC:VPTDF) a leaderin AI-enhanced cardiac imaging solutions, is proud to announce atransformative partnership with Nisg?a’a Valley Health Authority(NVHA) that is the next step towards forming a groundbreaking newmodel for delivering accessible, high-quality heart care powered byartificial intelligence.

The new model follows a “hub-and-spoke” design,where a central hub with advanced cardiac capabilities providessupport to connected sites in smaller, remote, and Indigenouscommunities. Local healthcare providers can acquire, enhance and readultrasound scans using VMS+™ and transmit them digitally as neededto specialists at the hub for rapid interpretation andconsultation.

The Nisg?a’a Valley Health Authority will serve asthe first remote site in this expanding network, and will be linked toa regional centre with tertiary and quaternary care capabilities.Future phases are intended to include:

?        Additional First Nations communities inBritish Columbia and all of Canada

?        Arctic regions across the country

?        Rural and northern communitiesworldwide

?        Communities in the Amazon, Africa,India, and other regions where MRI access is limited

This expected results of the model are simple yetprofound: delivering advanced cardiac imaging directly to patients -Indigenous and non-Indigenous - without the need for long-distancetravel, high costs, or extended wait times.

At the core of this model is Ventripoint’s VMS+™system, which delivers MRI-level heart measurement accuracy bytransforming standard 2D echocardiograms into 3D volumetric images.This technology enables precise cardiac assessments to be performed atthe point of care, reducing costs and eliminating the need fortime-consuming MRI scans. The system is already being used to supportdiagnosis and monitoring of indications such as congenital heartdisease, post-surgical recovery, chemotherapy-related cardiaccomplications, pulmonary hypertension, heart failure, and valvedysfunction.

“Ventripoint is a made-in-Canada innovation alreadyin use across Canada, the United States, Europe, and the UnitedKingdom,” said Hugh MacNaught, CEO of Ventripoint. “Through ourcollaboration with the Nisg?a’a Valley Health Authority, we arecreating a scalable model of heart care that can extend from theArctic to the Amazon, ensuring that everyone, regardless of geography,has access to advanced diagnostics.”

Corinne McKay, CEO, Nisga’a Valley Health Authority,said: "Our responsibility is to ensure that every Nisga’acitizen - wherever they live - has access to the highest standard ofcare, no matter where they live here in the Nass or urban centers ofTerrace or Vancouver. Partnering with Ventripoint allows us to explore innovative tools thatsupport more accurate diagnoses, faster treatment decisions, and trulypatient-centred care right here at home. For NVHA, this collaborationis about more than technology; it is about advancing healthsovereignty for the Nisga’a people and strengthening our ability toserve our people with excellence, compassion, and culturalintegrity."

Ventripoint plans to expand this model throughoutCanada and internationally, advancing the goal of universal access toaffordable, accurate cardiac diagnostics.

About Ventripoint DiagnosticsLtd.

Ventripoint is an industry leaderin the application of AI (Artificial Intelligence) toechocardiography. Ventripoint's VMS products are powered by itsproprietary Knowledge Based Reconstruction technology, which is theresult of a decade of development and provides accurate volumetriccardiac measurements equivalent to MRI. This affordable, gold-standardalternative allows cardiologists greater confidence in the managementof their patients. Providing better care to patients serves as aspringboard and basic standard for all of Ventripoint's productsthat guide our future developments. In addition, VMS+™ is versatileand can be used with all ultrasound systems from any vendor supportedby regulatory market approvals in the U.S., Europe, and Canada.

Nisg?a’a Valley HealthAuthority

The Nisg?a’a Valley Health Authority (NVHA) is thefirst fully accredited First Nations health authority in BritishColumbia and a cornerstone of health and wellness for the Nisg?a’apeople. Established in 1984, NVHA provides culturally grounded,community-led health services to Nisg?a’a citizens throughout theNass Valley and in urban centres such as Prince Rupert, Terrace andVancouver. NVHA integrates modern medical practices with Nisg?a’acultural knowledge and values, offering programs in primary care,mental health, chronic disease management, maternal and child health,crisis response, and community wellness. The organization continues toexpand its services and advance the health sovereignty of theNisg?a’a - honouring the past while building a healthier future forgenerations to come.

For further information, pleasecontact:

Hugh MacNaught

hmacnaught@ventripoint.com

604-671-4201

Neither the TSX Venture Exchange nor its RegulationServices Provider (as that term is defined in the policies of the TSXVenture Exchange) accepts responsibility for the adequacy or accuracyof this news release.

Forward Looking Statements

This news release contains forward-looking statementsand forward-looking information within the meaning of applicablesecurities laws. The use of any of the words "expect","anticipate", "continue", "estimate","objective", "ongoing", "may","will", "project", "should","believe", "plans", "intends'' andsimilar expressions are intended to identify forward-lookinginformation or statements. The forward-lookingstatements and information are based on certain key expectations andassumptions made by the Company. Although the Company believes thatthe expectations and assumptions on which such forward-lookingstatements and information are based are reasonable, undue relianceshould not be placed on the forward-looking statements and informationbecause the Company can give no assurance that they will prove to becorrect.

Since forward-looking statements and informationaddress future events and conditions, by their very nature theyinvolve inherent risks and uncertainties. Actual results could differmaterially from those currently anticipated due to a number of factorsand risks. Factors which could materially affect such forward-lookinginformation are described in the risk factors in the Company'smost recent annual management's discussion and analysis that isavailable on the Company's profile on SEDAR at www.sedar.com. Readers arecautioned that the foregoing list of factors is not exhaustive. Theforward-looking statements included in this news release are expresslyqualified by this cautionary statement. The forward-looking statementsand information contained in this news release are made as of the datehereof and the Company undertakes no obligation to update publicly orrevise any forward-looking statements or information, whether as aresult of new information, future events or otherwise, unless sorequired by applicable securities laws.

Copyright (c) 2025 TheNewswire - All rights reserved.